BGJb medium was developed for the growth of fetal rat long bones in a chemically defined medium. BGJb is a medium modified by Sylvia Fitton-Jackson from the original BGJ medium developed by Biggers, Gwatkin, and Judah. BGJb medium creates favorable conditions for growth and calcification of fetal bones.
This BGJb medium is manufactured as follows:| With | Without |
| • L-glutamine | • HEPES |
The complete
formulation is available.
Gibco™ BGJb medium contains higher levels of amino acids and glucose, and an increased buffering capacity to improve the conditions for growth and calcification of fetal bone.
Product Intended UseFor
in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the labeled intended use may be a violation of local law.
cGMP ManufacturingGibco™ BGJb medium is manufactured at a cGMP compliant facility located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.
BME contains no proteins, lipids, or growth factors. Therefore, BME requires supplementation, commonly with 10%
Fetal Bovine Serum (FBS). BME uses a sodium bicarbonate buffer system (3.5 g/L) and therefore requires a 5-10% CO
2 environment to maintain physiological pH.
This product is not used for in vitro diagnostic purpose in some countries.For Research Use Only. Not for use in diagnostic procedures. Not for human or animal therapeutic use. Uses other than the labeled intended use may be a violation of local law. For in vitro diagnostic use.